Aggravated bone density decline following symptomatic osteonecrosis in children with acute lymphoblastic leukemia

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Haematologica

• Publication date

  2015-06-09

• Fields of study

  Medicine

• Identifiers
  DOI 10.3324/haematol.2015.125583PMID 26405155PMCID PMC4666332
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Utility of early screening magnetic resonance imaging for extensive hip osteonecrosis in pediatric patients treated with glucocorticoids.

  2015cited by this paper
• Bone mineral density after childhood cancer in 346 long-term adult survivors of childhood cancer

  2015cited by this paper
• Bone mineral density at diagnosis determines fracture rate in children with acute lymphoblastic leukemia treated according to the DCOG-ALL9 protocol.

  2014cited by this paper
• Management and treatment of osteonecrosis in children and adolescents with acute lymphoblastic leukemia

  2014cited by this paper
• Osteonecrosis in Paediatric Patients with Acute Lymphoblastic Leukaemia Treated on Co-ALL-07-03 Trial: a Single Centre Analysis

  2014cited by this paper
• Bone Mineral Density Deficits and Fractures in Survivors of Childhood Cancer

  2013cited by this paper
• Effectiveness of pamidronate as treatment of symptomatic osteonecrosis occurring in children treated for acute lymphoblastic leukemia

  2013cited by this paper
• Bone mineral density deficits in childhood cancer survivors: Pathophysiology, prevalence, screening, and management

  2013cited by this paper
• Selective reduction in trabecular volumetric bone mineral density during treatment for childhood acute lymphoblastic leukemia.

  2012cited by this paper
• Prospective study on incidence, risk factors, and long-term outcome of osteonecrosis in pediatric acute lymphoblastic leukemia.

  2011cited by this paper
• Germline variation in the MTHFR and MTRR genes determines the nadir of bone density in pediatric acute lymphoblastic leukemia: a prospective study.

  2011cited by this paper
• Influence of Sports Participation on Bone Health in the Young Athlete: A Review of the Literature

  2011influential reference
• Management of osteonecrosis in children and young adults with acute lymphoblastic leukaemia

  2011cited by this paper
• Pharmacogenetic risk factors for altered bone mineral density and body composition in pediatric acute lymphoblastic leukemia

  2010cited by this paper
• Prospective bone ultrasound patterns during childhood acute lymphoblastic leukemia treatment.

  2010cited by this paper
• Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemia.

  2010cited by this paper
• Long-term results of Dutch Childhood Oncology Group studies for children with acute lymphoblastic leukemia from 1984 to 2004

  2010cited by this paper
• Dexamethasone-based therapy for childhood acute lymphoblastic leukaemia: results of the prospective Dutch Childhood Oncology Group (DCOG) protocol ALL-9 (1997-2004).

  2009cited by this paper
• Effect of swimming on bone metabolism in adolescents.

  2008influential reference
• Official Positions of the International Society for Clinical Densitometry and executive summary of the 2007 ISCD Pediatric Position Development Conference.

  2008cited by this paper
• High-dose compared with intermediate-dose methotrexate in children with a first relapse of acute lymphoblastic leukemia.

  2008cited by this paper
• Special report on the 2007 adult and pediatric Position Development Conferences of the International Society for Clinical Densitometry

  2008cited by this paper
• Impaired dexamethasone-related increase of anticoagulants is associated with the development of osteonecrosis in childhood acute lymphoblastic leukemia

  2008cited by this paper
• Osteonecrosis in children and adolescents with cancer

  2008cited by this paper
• Incidence and Outcome of Osteonecrosis in Children and Young Adults with Acute Lymphoblastic Leukaemia Treated on a Dexamethasone Containing Protocol: Results of the Medical Research Council UK Trial ALL 2003

  2008cited by this paper
• Definition of bone necrosis by the pathologist.

  2007cited by this paper
• Two-week longitudinal survey of bone architecture alteration in the hindlimb-unloaded rat model of bone loss: sex differences.

  2006cited by this paper
• Bone Mineral Density Decrements and Children Diagnosed With Cancer

  2005cited by this paper
• Osteonecrosis: A treatment related toxicity in childhood acute lymphoblastic leukemia (ALL)—experiences from trial ALL‐BFM 95

  2005cited by this paper
• Skeletal morbidity in childhood acute lymphoblastic leukaemia

  2005cited by this paper
• MRI of osteonecrosis.

  2004cited by this paper
• CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment.

  2003cited by this paper
• The impact of skeletal unloading on bone formation.

  2003cited by this paper
• Reference data for bone density and body composition measured with dual energy x ray absorptiometry in white children and young adults

  2002cited by this paper
• Altered bone mineral density and body composition, and increased fracture risk in childhood acute lymphoblastic leukemia.

  2002cited by this paper
• Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group.

  2000cited by this paper
• The response of bone to unloading

  1999cited by this paper
• The Effects of Twelve Weeks of Bed Rest on Bone Histology, Biochemical Markers of Bone Turnover, and Calcium Homeostasis in Eleven Normal Subjects

  1998cited by this paper
• Bone and mineral abnormalities in childhood acute lymphoblastic leukemia: Influence of disease, drugs and nutrition

  1998cited by this paper
• Glucocorticoid osteoporosis--mechanisms and management.

  1997cited by this paper
• Altered mineral metabolism and bone mass in children during treatment for acute lymphoblastic leukemia

  1996cited by this paper
• Applied Linear Statistical Models (3rd ed.).

  1992cited by this paper
• Nontraumatic necrosis of bone (osteonecrosis).

  1992cited by this paper
• Bone mineral loss and recovery after 17 weeks of bed rest

  1990cited by this paper
• Effects of a 120 day period of bed-rest on bone mass and bone cell activities in man: attempts at countermeasure.

  1987cited by this paper
• Bone marrow magnetic resonance studies in childhood leukemia. Evaluation of osteonecrosis

  1987cited by this paper
• Inhibition of cortical and trabecular bone formation in the long bones of immobilized monkeys.

  1983cited by this paper
• Applied Linear Statistical Models

  1975cited by this paper
• Efficiency of case-control studies with multiple controls per case: continuous or dichotomous data.

  1975influential reference
• Osteoporotic fractures secondary to methotrexate therapy of acute leukemia in remission

  1970cited by this paper
• Individual matching with multiple controls in the case of all-or-none responses.

  1969influential reference

• Multifocal osteonecrosis as well as repeated bone fractures due to osteoporosis in a prepubertal ALL case

  2025cites this paper
• Bone mineral density in childhood cancer survivors during and after oncological treatment: A systematic review and meta-analysis

  2025cites this paper
• Causal relationship between osteoporosis, bone mineral density, and osteonecrosis: a bidirectional two-sample Mendelian randomization study

  2025cites this paper
• Novel Therapeutic Approaches in Pediatric Acute Lymphoblastic Leukemia

  2025cites this paper
• Bisphosphonate treatment for skeletal complications in paediatric cancer—Experience from a single tertiary centre

  2024cites this paper
• ALKBH5 promotes T-cell acute lymphoblastic leukemia growth via m6A-guided epigenetic inhibition of miR-20a-5p.

  2024cites this paper
• Bone health in childhood cancer survivors, is there really a problem? Pitfalls of assessment, calculating risk, and suggested surveillance and management for osteonecrosis and low and very low bone mineral density

  2024influential citation
• Clinical Efficacy and Safety of CD7-Targeted CAR T Cell Therapy for T-cell Malignancies: A Systematic Review and Meta-analysis.

  2024cites this paper
• Clinical features, laboratory characteristics, and outcome of ETP and TCRA/D aberrations in pediatric patients with T-acute lymphoblastic leukemia

  2023cites this paper
• Osteonecrosis in Children and Young Adults Treated for Acute Lymphoblastic Leukemia: A Scoping Review

  2023cites this paper
• Reductions in Bone Mineral Density Are Apparent Early in Children With Prevalent Osteonecrosis Lesions Following Leukemia Therapy

  2023cites this paper
• Animal Models of Acute lymphoblastic leukemia: recapitulating the human disease to evaluate drug efficacy and discover therapeutic targets.

  2022cites this paper
• Orthopaedic adverse events among adolescents and adults treated with asparaginase for acute lymphoblastic leukaemia

  2022cites this paper
• A Validated Risk Prediction Model for Bone Fragility in Children With Acute Lymphoblastic Leukemia

  2021cites this paper
• Osteonecrosis in Adults With Acute Lymphoblastic Leukemia: An Unmet Clinical Need

  2021cites this paper
• Recent perspectives on the association between osteonecrosis and bone mineral density decline in childhood acute lymphoblastic leukemia

  2021cites this paper
• Combination therapy with miR-34a and doxorubicin synergistically induced apoptosis in T-cell acute lymphoblastic leukemia cell line

  2021cites this paper
• [β-arrestin1 overexpression suppresses progression of human T-cell acute lymphatic leukemia Molt-4 cell xenograft in mice].

  2020cites this paper
• Incidence of hip and knee osteonecrosis and their associations with bone mineral density in children with acute lymphoblastic leukaemia

  2020cites this paper
• Gambogic acid inhibits proliferation and induces apoptosis of human acute T‑cell leukemia cells by inducing autophagy and downregulating β‑catenin signaling pathway: Mechanisms underlying the effect of Gambogic acid on T‑ALL cells.

  2020cites this paper
• Comparing osteonecrosis clinical phenotype, timing, and risk factors in children and young adults treated for acute lymphoblastic leukemia

  2018cites this paper
• Development and feasibility of Mandarin‐language bone health scales for adolescents with cancer in Taiwan

  2018cites this paper
• The genetics and molecular biology of T-ALL.

  2017cites this paper
• Medical Supportive Care for Treatment-Related Toxicity in Childhood ALL

  2017cites this paper
• Systematic Review and Meta-Analysis of the Proportion of Pediatric Acute Lymphoblastic Leukemia (ALL) Cases that Develop Osteonecrosis

  2017cites this paper
• MicroRNA expression and activity in T-cell acute lymphoblastic leukemia

  2017cites this paper
• Non-infectious chemotherapy-associated acute toxicities during childhood acute lymphoblastic leukemia therapy

  2017cites this paper
• Genetic Biomarkers to Identify the Risk of Osteonecrosis in Children with Acute Lymphoblastic Leukemia

  2016cites this paper
• Osteonecrosis in children with acute lymphoblastic leukemia

  2016cites this paper